NASDAQ:BCRX   BioCryst Pharmaceuticals, Inc.
Entry price: 8.27

Fundamentals:

- Sector: Medical - Biotech

- EPS % Chg (Last Qtr): 24%

- EPS % Chg (Previous Qtr): 24%%

- 3 Year EPS Growth Rate: 0%

- EPS Est % Chg (Current Yr): 0%

- Sales % Chg (Last Qtr): 243%

- Sales % Chg (Previous Qtr): 98%

- 3-Year Sales Growth Rate: 25%

- Annual Pre -Tax Margin: -223%
評論:
Added
Average price: 7.99
評論:
_________________________
- EPS % Chg (Last Qtr): -1600%
- Sales % Chg (Last Qtr): -90%
評論:
Sold at 11.04
Return: +38.06%
評論:

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。